8-K
Sanara MedTech Sells Tissue Health Plus Assets for $2 Million
8-K
Sanara MedTech and MiMedx Receive FTC Second Request Regarding Proposed Merger
8-K
Sanara MedTech Shareholders Approve Merger Agreement with MiMedx
8-K
Sanara MedTech Reports Second Quarter 2026 Financial Results and Pending Acquisition by MIMEDX
8-K/A
Merger Agreement Amended to Correct Termination Fees; Sanara MedTech to Merge with MiMedx Group, Inc.
8-K
MIMEDX to Acquire Sanara MedTech for $350 Million
